ANDA Approvals Break Record, May Set New Normal
FDA's June approval total is highest of GDUFA era, but does it signal a new elevated productivity level for the generics program?

FDA's June approval total is highest of GDUFA era, but does it signal a new elevated productivity level for the generics program?